Tilray Brands, Inc. Retained Earnings
Tilray Brands, Inc. (TLRY) had Retained Earnings of -$4.97 billion as of 2026-05-31, per its 10-K filed 2026-07-28.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-07-28
- 2026-05-31: Retained Earnings (Accumulated Deficit) -$4.97B.
- 2026-02-28: Retained Earnings (Accumulated Deficit) -$4.92B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$4.85B.
- 2025-11-30: Retained Earnings (Accumulated Deficit) -$4.89B.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-05-31 | -$4.97B 10-K · filed 2026-07-28 |
| 2026-02-28 | -$4.92B 10-Q · filed 2026-04-01 |
| 2025-12-31 | -$4.85B 10-K · filed 2026-07-28 |
| 2025-11-30 | -$4.89B 10-Q · filed 2026-01-08 |
| 2025-08-31 | -$4.85B 10-Q · filed 2025-10-09 |
| 2025-05-31 | -$4.85B 10-Q · filed 2026-04-01 |
| 2024-12-31 | -$3.57B 10-Q · filed 2025-04-08 |
| 2024-11-30 | -$2.78B 10-Q · filed 2025-01-10 |
| 2024-08-31 | -$2.70B 10-Q · filed 2024-10-10 |
| 2024-05-31 | -$2.66B 10-K · filed 2025-07-29 |
| 2024-02-29 | -$2.63B 10-Q · filed 2024-04-09 |
| 2023-12-31 | -$2.66B 10-Q · filed 2025-04-08 |
| 2023-11-30 | -$2.54B 10-Q · filed 2024-01-09 |
| 2023-08-31 | -$2.49B 10-Q · filed 2024-10-10 |
| 2023-05-31 | -$2.42B 10-Q · filed 2024-10-10 |
| 2023-02-28 | -$2.28B 10-Q · filed 2023-04-10 |
| 2022-11-30 | -$1.11B 10-Q · filed 2023-01-09 |
| 2022-08-31 | -$1.04B 10-Q · filed 2022-10-07 |
| 2022-05-31 | -$962.85M 10-K · filed 2023-07-26 |
| 2022-03-31 | -$962.85M 10-Q · filed 2023-01-09 |
| 2022-02-28 | -$484.71M 10-Q · filed 2022-04-06 |
| 2021-11-30 | -$527.90M 10-Q · filed 2022-01-10 |
| 2021-08-31 | -$527.70M 10-Q · filed 2021-10-07 |
| 2021-05-31 | -$486.05M 10-K · filed 2022-07-28 |
| 2021-03-31 | -$1.07B 10-Q · filed 2021-05-10 |
| 2020-12-31 | -$730.10M 10-Q · filed 2021-05-10 |
| 2020-09-30 | -$727.16M 10-Q · filed 2020-11-09 |
| 2020-06-30 | -$724.84M 10-Q · filed 2020-08-10 |
| 2020-05-31 | -$113.35M 10-K · filed 2021-07-28 |
| 2020-03-31 | -$643.15M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$430.13M 10-K · filed 2021-02-19 |
| 2019-09-30 | -$209.21M 10-Q · filed 2019-11-13 |
| 2019-06-30 | -$173.53M 10-Q · filed 2019-08-13 |
| 2019-03-31 | -$138.48M 10-Q · filed 2019-05-15 |
| 2018-12-31 | -$108.18M 10-K · filed 2020-03-02 |
| 2018-09-30 | -$77.17M 10-Q · filed 2018-11-14 |
| 2018-06-30 | -$58.47M 10-Q · filed 2018-08-29 |
| 2017-12-31 | -$40.45M 10-K · filed 2019-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |